1.Regulation of Axon Initial Segment Diameter by COUP-TFI Fine-tunes Action Potential Generation.
Xuanyuan WU ; Haixiang LI ; Jiechang HUANG ; Mengqi XU ; Cheng XIAO ; Shuijin HE
Neuroscience Bulletin 2022;38(5):505-518
The axon initial segment (AIS) is a specialized structure that controls neuronal excitability via action potential (AP) generation. Currently, AIS plasticity with regard to changes in length and location in response to neural activity has been extensively investigated, but how AIS diameter is regulated remains elusive. Here we report that COUP-TFI (chicken ovalbumin upstream promotor-transcription factor 1) is an essential regulator of AIS diameter in both developing and adult mouse neocortex. Either embryonic or adult ablation of COUP-TFI results in reduced AIS diameter and impaired AP generation. Although COUP-TFI ablations in sparse single neurons and in populations of neurons have similar impacts on AIS diameter and AP generation, they strengthen and weaken, respectively, the receiving spontaneous network in mutant neurons. In contrast, overexpression of COUP-TFI in sparse single neurons increases the AIS diameter and facilitates AP generation, but decreases the receiving spontaneous network. Our findings demonstrate that COUP-TFI is indispensable for both the expansion and maintenance of AIS diameter and that AIS diameter fine-tunes action potential generation and synaptic inputs in mammalian cortical neurons.
Action Potentials
;
Animals
;
Axon Initial Segment
;
COUP Transcription Factor I
;
DNA-Binding Proteins/physiology*
;
Mammals
;
Mice
;
Transcription Factors
2.Analysis of NR2F1 gene variant in a child with optic atrophy and global developmental delay.
Yang TIAN ; Jiahao CAI ; Xufang LI ; Lianfeng CHEN ; Ting KANG ; Wenxiong CHEN
Chinese Journal of Medical Genetics 2023;40(10):1301-1305
OBJECTIVE:
To explore the genetic basis for a child with optic atrophy and global developmental delay.
METHODS:
A child who had presented at the Guangzhou Women and Children's Medical Center in January 2022 was selected as the study subject. Clinical data were collected. Whole exome sequencing (WES) was carried out for the child. Candidate variant was validated by Sanger sequencing and bioinformatic analysis.
RESULTS:
The child, a nine-month-old female, had manifested dysopia and global developmental delay. Genetic testing revealed that she has harbored a de novo c.425G>C (p.Arg142Pro) variant of the NR2F1 gene, which has been associated with Bosch-Boonstra-Schaaf syndrome. Based on the guidelines from the American College of Medical Genetics and Genomics (ACMG), the variant was classified as pathogenic (PS2+PM1+PM2_Supporting+PM5+PP3+PP4).
CONCLUSION
The c.425G>C (p.Arg142Pro) variant of the NR2F1 gene probably underlay the pathogenesis in this child. Above finding has enriched the genotypic and phenotypic spectrum of the NR2F1 gene.
Female
;
Humans
;
Infant
;
Computational Biology
;
COUP Transcription Factor I/genetics*
;
Genetic Testing
;
Genomics
;
Genotype
;
Optic Atrophy/genetics*